(Q30365882)

English

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

based on heuristic

inferred from title

influenza vaccine

0 references

8

object named as

Albert D M E Osterhaus

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

7

object named as

Ron A M Fouchier

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Guus Rimmelzwaan

10

object named as

Guus F Rimmelzwaan

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Stella E Vogelzang-van Trierum

4

object named as

Stella E Vogelzang-van Trierum

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Nella J Nieuwkoop

5

object named as

Nella J Nieuwkoop

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Carolien E van de Sandt

1

object named as

Carolien E van de Sandt

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Joost H C M Kreijtz

2

object named as

Joost H C M Kreijtz

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Martina M Geelhoed-Mieras

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

David A M C van de Vijver

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Bror Morein

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

17 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

5614-5623

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Influenza virus: a master of metamorphosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

The genomic and epidemiological dynamics of human influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Mapping the antigenic and genetic evolution of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

The contents of the syringe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Structural basis of immune recognition of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

A highly conserved neutralizing epitope on group 2 influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Protection of mice with recombinant influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Cellular immune correlates of protection against symptomatic pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Iscoms Containing PurifiedQuillajaSaponins Upregulate both Th1-like and Th2-like Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Immune up regulatory response of a non-caloric natural sweetener, stevioside

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

The novel adjuvant CoVaccineHT™ increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Functional aspects of iscoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Yearly influenza vaccinations: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Evolution of H5N1 avian influenza viruses in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Pre-pandemic and pandemic influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Adapting global influenza management strategies to address emerging viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Selection of influenza vaccine strains and developing pandemic vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Airborne transmission of influenza A/H5N1 virus between ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Limited airborne transmission of H7N9 influenza A virus between ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2014.08.003

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30365882&oldid=1872433211"